forecast
GLP-1s Could Expand Surgical Eligibility
If GLP-1 drugs cause weight loss, morbidly obese patients previously judged too high-risk for other surgeries could become eligible, potentially expanding the addressable market for robotic surgery.
forecastpending
Speaker
Joe ThomasEvidence Quote
“some morbidly obese patients are considered too high risk to operate on for other non-bariatric procedures.”
Created: 11/17/2026, 9:04:47 PM
Your notes
Loading notes...